Next Generation Sequencing Services Market to Grow with a CAGR of 22.92% through 2030

Increasing prevalence of genetic disorders and advancements in genomic technologies is expected to drive the growth of Global Next Generation Sequencing Services Market in the forecast period, 2026-2030.

According to TechSci Research report, “Next Generation Sequencing Services Market –Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, Next Generation Sequencing Services Market stood at USD 5.97 billion in 2024 and is anticipated to grow with a CAGR of 22.92% in the forecast period through 2030. This can be ascribed in the forecasted years due to advancements in genomic technologies, increasing demand for precision medicine, growing application of next generation sequencing in clinical research, and increasing prevalence of genetic disorders.

Whole exome sequencing (WES) is increasingly being used in research and clinical settings for identifying disease-causing mutations. This has led to a growing demand for WES services, which is expected to drive the growth of the NGS services market in the coming years. These tests enable rapid and accurate identification of the virus and its variants, enabling governments and healthcare organizations to control the spread of the disease.

Furthermore, the pandemic has highlighted the importance of NGS technology in healthcare and research. Governments and healthcare organizations worldwide have recognized the need to invest in NGS technology to prepare for future pandemics and to improve healthcare outcomes.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Next Generation Sequencing Services Market"

Global Next Generation Sequencing Services Market can be segmented based on service, workflow, end user, regional distribution and company.

Based on workflow, the data analysis category is projected to experience the fastest growth in the global Next Generation Sequencing (NGS) services market over the forecast period. This rapid growth is driven by the exponentially increasing volume of sequencing data generated by advanced platforms, which demands sophisticated, scalable, and accurate analytical tools for interpretation. As sequencing costs decrease and throughput increases, researchers and clinicians are producing larger and more complex datasets. Interpreting these datasets requires robust bioinformatics pipelines and data analytics frameworks capable of handling raw sequence alignment, variant calling, gene annotation, and expression profiling. Consequently, demand has surged for both in-house and cloud-based data analysis services that can deliver fast, reproducible, and clinically actionable insights.

Based on Region, Asia Pacific is showing the fastest growth in the global Next Generation Sequencing (NGS) services market. This rapid expansion can be attributed to increasing investments in genomics research, growing awareness of precision medicine, and a rising prevalence of genetic disorders and chronic diseases across several countries in the region. Nations such as China, India, Japan, and South Korea are at the forefront of this growth, driven by national genome projects, public-private partnerships, and rising government funding dedicated to life sciences and biotechnology. Moreover, the healthcare infrastructure in many Asia Pacific countries is undergoing rapid modernization. Governments and private institutions are working together to build advanced genomic laboratories, implement NGS-based diagnostic workflows, and train healthcare professionals in the application of these technologies. For example, China’s “Precision Medicine Initiative” and India’s “Genome India Project” are national efforts aimed at boosting genetic research and personalized healthcare, thereby fostering the growth of the NGS services market.

Major companies operating in Global Next Generation Sequencing Services Market are:

• Quest Diagnostics Inc.
• Applied Biological Materials, Inc.
• Novogene Co, Ltd.
• Azenta Life Sciences (GENEWIZ)
• NanoString Technologies, Inc.
• Illumina, Inc.
• PacBio, Inc.
• Gene by Gene Ltd
• Lucigen Corporation
• ARUP Laboratories

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Next Generation Sequencing (NGS) Market is experiencing rapid growth and is expected to continue to do so in the coming years. NGS technology has revolutionized genomics research and has numerous applications in fields such as drug discovery, clinical diagnostics, and personalized medicine. The increasing prevalence of genetic disorders and cancer, growing demand for precision medicine, and decreasing cost of NGS technology are driving the market's growth. Additionally, the COVID-19 pandemic has accelerated the adoption of NGS technology in COVID-19 research and diagnostics, further boosting the market's growth. Key players in the NGS market include Illumina, Novogene, and Lucigen Corporation.” said Mr. Karan Chechi, Research Director of TechSci Research, a research based global management consulting firm.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com